Status:
UNKNOWN
Transcranial Direct Current Stimulation on Inhibitory Control in Addictions.
Lead Sponsor:
Universidad de Almeria
Collaborating Sponsors:
Junta de Andalucia
Conditions:
Substance-Related Disorders
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The research in neuroscience of the last 20 years is defined, in addition to continuing to advance in the field of behavioral and pharmacological therapy, by the birth and development of a new therape...
Detailed Description
The research in behavioral neuroscience of the last 20 years is defined, in addition to continuing to advance in the field of behavioral and pharmacological therapy, by the birth and development of a ...
Eligibility Criteria
Inclusion
- Substance abuse
- Under clinical treatment at the Noesso Addiction Rehabilitation Center La Quinta, Laujar de Andarax, Spain
- Participation approved by the clinical team
- Participation approved by the experimental team by means of the Göttingen screening questionnaire
- Signed informed consent
- At least 26 points in the Montreal Cognitive Assessment (MOCA) evaluation
Exclusion
- Epilepsy or history of epilepsy (convulsions due compsumtion not included)
- Cardiopathy or cardiac electronic devices
- Skin reaction or high sensitivity to tDCS
- Head metallic implant
- Serious mental disease
- Exclusion because of clinical criteria (physician, psychologist)
Key Trial Info
Start Date :
April 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05350033
Start Date
April 5 2021
End Date
December 31 2022
Last Update
April 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychobiology Lab
Almería, Spain, 04120